- On Air Program Guide
- A Blue View
- Brain Talk
- Cellar Notes
- Choral Arts Classics
- The Environment in Focus
- Gil Sandler’s Baltimore Stories
- Humanities Connection
- Maryland Morning with Sheilah Kast
- Midday with Dan Rodricks
- The Morning Economic Report
- Radio Kitchen
- The Signal
- Take Five
- Your Maryland
- Public Commentary
- War of 1812 Stories
Rockville company’s drug to be tested in U.S.
Synthetic Biologics Inc., of Rockville, which develops and commercializes medicines derived from synthetic biology, said its Swedish sublicensee, Meda AB, received approval from U.S. regulators to conduct a Phase II study of a new drug being developed for the treatment of fibromyalgia.
IN FOCUS TODAY
Thursday, May 23, 2013 - 4:50am
The taxpayers of Baltimore are about to front a developer $107 million in something called tax...
Wednesday, May 22, 2013 - 6:35am
WYPR's Fraser Smith and political consultant and columnist Laslo Boyd talk about how Baltimore...
Tuesday, May 21, 2013 - 4:44am
For Baltimore businesses, this is "Clean Your Files" day, part of the city's campaign to...